Literature DB >> 2850684

[The renin-angiotensin system: systemic and local function].

P Gohlke1, D Ganten, R E Lang, T Unger.   

Abstract

The renin-angiotensin system (RAS) has long been known as a hormonal system, which is important for the maintenance of volume homeostasis, and which contributes under certain circumstances to the pathogenesis of hypertension and cardiac failure. More recent findings have demonstrated that the individual components of this system can also be synthesized locally in tissue, e.g. in the brain, the vascular wall, the kidney, the adrenals, and the heart. Although the role of locally generated angiotensin within cardiovascular- and body volume regulation needs to be further investigated, it has already become clear that the mechanism of action of drugs interfering with the RAS is not confined to the circulating RAS, but also includes an interaction with local renin-angiotensin systems. These agents, particularly the converting enzyme inhibitors, have proved to be indispensible tools for elucidating the function of local renin-angiotensin systems, in addition to being therapeutically useful in the treatment of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850684

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  4 in total

Review 1.  Control of energy balance by the brain renin-angiotensin system.

Authors:  Kristin E Claflin; Justin L Grobe
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 2.  Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.

Authors:  F Deget; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons.

Authors:  Amit K Mitra; Lie Gao; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-16       Impact factor: 4.249

Review 4.  The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.

Authors:  Iryna Liauchonak; Fady Dawoud; Yatin Riat; Bessi Qorri; Manpreet Sambi; Justin Jain; Regina-Veronicka Kalaydina; Nicole Mendonza; Komal Bajwa; Myron R Szewczuk
Journal:  Int J Mol Sci       Date:  2018-02-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.